Based in Massachusetts (US), Ironwood is an entrepreneurial pharmaceutical company that discovers, develops and intends to commercialize innovative human medicines. The company’s IPO was the largest of the biotechnology industry in the US in 2010. Biominas’ goal was to evaluate the Brazilian market attractiveness for Ironwood’s first product, linaclotide, design a regulatory pathway and required commercial investment for a market entry.
- Market size estimate, discussion of pricing issues and financial projections for a 5-year period;
- Organization of a business development trip to Brazil.
“Biominas has helped augment our understanding of the Brazilian healthcare system in general and the market opportunity for linaclotide, our lead product candidate in particular. Following our project we have a much better grasp of the regulatory landscape, the pricing and reimbursement issues and the necessary commercial strategies to succeed in Brazil”.